Vitamin B9 in real specimens. |
SPE modified with La+3/Co3O4 nano-cubes. |
0.3 µM |
1–600 µM |
Human urine samples, tablet. |
[58] |
N-acetylcysteine in the presence of paracetamol and folic acid |
CPE modified with Pt-Co nanoparticles and 2-(3,4 dihydroxy phenethyl) isoindoline-1,3-dione |
0.04 µM |
0.08–650 µM |
Human urine samples, tablet. |
[59] |
Simultaneous determination of sulfisoxazole and folic acid. |
CuO Nanoparticles decorated on SWCNT nanocomposite modified CPE. |
0.8 µM |
0.07–500 µM |
Human urine and tablet. |
[59] |
Folic acid in real specimens. |
SPE modified with Graphene Oxide Nanoribbons |
0.02 µM |
0.1–1600 µM |
Human urine samples, tablet |
[60] |
Folic acid in real specimens. |
Mn-zeolite/Graphite modified Screen-printed Carbon Electrode |
0.003 µM |
0.004–1 µM |
Pharmaceutical samples |
[61] |
Folic acid in real specimens. |
SPE modified using GNS-MoS2-AuNPs |
38.5 nM |
50 nM–1150 µM |
Human urine |
[62] |
Simultaneous determination of folic acid and epinephrine |
Graphite SPE modified with Fe3O4@SiO2
|
1 μM |
5–1000 μM |
Human blood serum and urine |
[63] |
Folic acid in real specimens. |
SPE modified with NiFe2O4 nanoparticles |
0.034 μM |
0.1–500 μM |
Human urine |
[64] |